Righthand Richard N MD is categorized under Internal Medicine Doctors in Cliffside Park, NJ and active since 1988.
Righthand Richard N MD was established in 1988, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Richard Righthand at the company’s single location by writing to 691 Palisade Avenue, Cliffside Park, New Jersey NJ 07010 or by phoning (201) 943-0689. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Righthand Richard N MD |
| Contact Person: | Richard Righthand |
| Address: | 691 Palisade Avenue, Cliffside Park, New Jersey 07010 |
| Phone Number: | (201) 943-0689 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 1988 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Internal Medicine Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Righthand Richard N MD was started in 1988 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Richard Righthand for inquiries that concern Righthand Richard N MD by calling the company number (201) 943-0689, as your correspondence is most welcome. Additionally, the physical location of the single location of Righthand Richard N MD can be found at the coordinates 40.825793,-73.982119 as well as the street address 691 Palisade Avenue in Cliffside Park, New Jersey 07010.
For its online presence, you may visit Righthand Richard N MD’s website at and engage with its social media outlets through on Twitter and on Facebook.